Palvella Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
PVLA
CUSIP
697947109
Type
Equity
Class
COM
Num filings
208
Total reported value, excl. options
$2.16 B
Manager Report Date Value ($000) Shares Option Type